Skip to content

Disclosure Information

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity—including faculty, planners, reviewers or others—are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Program Planners

The following planners have no relevant financial relationships to disclose:

  • Rebecca Brendel, M.D., J.D.
  • Eric R. Williams, M.D.
  • Josepha A. Cheong, M.D.
  • Alicia Barnes, D.O., M.P.H.
  • Lama Bazzi, M.D.
  • David R. Beckert, M.D.
  • J. Michael Bostwick, M.D.
  • Carlyle Hung-Lun Chan, M.D.
  • Hector Colon-Rivera, M.D.
  • Catherine Crone, M.D.
  • Jacqueline Feldman, M.D.
  • Tanuja Gandhi, M.D.
  • Amir Garakani, M.D.
  • Dhruv R. Gupta, M.D., M.S.
  • Vikas Gupta, M.D., M.P.H.
  • Danielle Hairston, M.D.
  • Dionne Hart, M.D.
  • John Luo, M.D.
  • Lawrence Malak, M.D.
  • Brandon Manor
  • Sofia Matta, M.D.
  • Jessica Mayer, M.D.
  • Philip R. Muskin, M.D., M.A.
  • Sarah C. Noble, D.O.
  • Lucy Ogbu-Nwobodo, M.D., M.S.
  • Uchenna B. Okoye, M.D.
  • Jacqueline Posada, M.D.
  • Diego Regalado
  • Karen B. Rosenbaum, M.D.
  • Julia Tartaglia, M.D.
  • Nhi-Ha Trinh, M.D., M.P.H.
  • Art C. Walaszek M.D.
  • Ronald Winchel, M.D.
  • Sean Woodward; Farah Zaidi, M.D.

Presenters

  • Ian Cook, M.D. has ownership Interest (includes stock, stock options, patent, or other intellectual property) in NeuroSigma, Inc., Other Los Angeles TMS Institute, HeartCloud, and BrainCloud Corporation
  • Maurizio Fava, M.D. has ownership Interest (includes stock, stock options, patent, or other intellectual property) in Eric Hollander, M.D. serves as a consultant for Jazz Pharmaceuticals and has received grant/research support from Jazz Pharmaceuticals.
  • Corey Keller, M.D., Ph.D. has ownership Interest (includes stock, stock options, patent, or other intellectual property) in Alto Neuroscience.
  • John Krystal, M.D. serves as a consultant for Biogen, Boehringer Ingelheim Pharmaceuticals, Janssen, Jazz Pharmacuetical, Neurocrine Biosciences, Inc., Novartis Pharmaceuticals. He has has ownership Interest (includes stock, stock options, patent, or other intellectual property) in Biohaven Pharmaceuticals, Damona Pharmaceuticals, Delix Therapeutics, Freedom Biosciences, EpiVario, Neumora Therapeutics, Spring Health, Temporo Bio, Terran Biosciences, and Tetricus Inc.
  • Alan Schatzberg, M.D. has ownership Interest (includes stock, stock options, patent, or other intellectual property) in Alto Neuroscience, ANeuroTech, and NeuraWell
  • Madhukar Trivedi, M.D. has ownership Interest (includes stock, stock options, patent, or other intellectual property) in Alto Neuroscience and Greenlight Vitalsign

The Faculty listed here have no financial relationships to disclose (.pdf).

Medical leadership for mind, brain and body.

Join Today